Skip to main content

Table 3 Comparison of liver and kidney function before and after PSE in each group

From: Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly

Group

Mean ± SD

t-test (P value)

PSE + Hep + DEX group (N = 54)

Bilirubin (μmol/L)

Before treatment

14.0 ± 5.1

0.265

  

Post Treatment

15.2 ± 5.1

 
 

Albumin (g/L)

Before treatment

35.27 ± 3.39

0.275

  

Post Treatment

34.42 ± 3.06

 
 

BUN (mmol/L)

Before treatment

5.67 ± 1.72

0.157

  

Post Treatment

5.96 ± 1.48

 
 

Cr (μmol/L)

Before treatment

74.1 ± 17.6

0.459

  

Post Treatment

72.2 ± 19.5

 

PSE group (N = 62)

Bilirubin (μmol/L)

Before treatment

13.9 ± 6.2

0.959

  

Post Treatment

13.8 ± 5.5

 
 

Albumin (g/L)

Before treatment

34.29 ± 3.64

0.235

  

Post Treatment

33.58 ± 2.99

 
 

BUN (mmol/L)

Before treatment

5.51 ± 1.47

0.001

  

Post Treatment

6.15 ± 1.49

 
 

Cr (μmol/L)

Before treatment

77.7 ± 19.8

0.541

  

Post Treatment

76.1 ± 20.9

Â